Maybe. But it's basically a good knife that is currently fetching about 60% less than its true value. Polish it up and the stock will get back to 120c. A bit like Murray Gouburn a few weeks ago.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025